Eyesense's Corporate Minority Round

Eyesense raised a round of funding on January 12, 2011. Investors include QIAGEN.

EyeSense develops an ophthalmic diagnostics system which can measure glucose levels without sampling blood. It is based on measuring the glucose in the interstitial fluid below the conjunctiva of the …

Articles about Eyesense's Corporate Minority Round: